MSB 1.01% $1.76 mesoblast limited

You are right. I stand corrected. Just checked the FDA guidance...

  1. 149 Posts.
    lightbulb Created with Sketch. 32
    You are right. I stand corrected. Just checked the FDA guidance on the subject.

    They also say:
    "The execution of an interim analysis should be a completely confidential process... All staff involved in the conduct of the trial should remain blind to the results of such analyses... This principle may be applied to all investigator staff and to staff employed by the sponsor except for those who are directly involved in the execution of the interim analysis. Investigators should be informed only about the decision to continue or discontinue the trial, or to implement modifications to trial procedures".

    It further says:
    "When a sponsor assumes the role of monitoring efficacy or safety comparisons and therefore has access to unblinded comparative information, particular care should be taken... to manage and limit appropriately the sharing of information."

    I guess if Teva took a lead in this process, they get to take a look.
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.128B
Open High Low Value Volume
$1.73 $1.79 $1.73 $2.745M 1.562M

Buyers (Bids)

No. Vol. Price($)
7 9897 $1.76

Sellers (Offers)

Price($) Vol. No.
$1.76 91050 21
View Market Depth
Last trade - 14.26pm 10/05/2021 (20 minute delay) ?
0.018 ( 1.36 %)
Open High Low Volume
$1.75 $1.79 $1.73 263141
Last updated 14.45pm 10/05/2021 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.